Campylobacter-stimulated INT407 cells produce dissociated cytokine profiles

Journal of Infection

Volumn 47, Issue 3, 2003, Pages 217-224

  Al Salloom, Fajer Subah ^a   Mahmeed, Ali Al ^a   Ismaeel, Abdulrahman ^a   Botta, Giuseppe A ^a   Bakhiet, Moiz ^a  

^a ARABIAN GULF UNIVERSITY   (Bahrain)

Author keywords

Campylobacter jejuni; Diarrhea; IFN ; IL 10; IL 4; TNF

Indexed keywords

BACTERIAL RNA; CELL PROTEIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CAMPYLOBACTER JEJUNI; CELL LINE; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; GRAM NEGATIVE INFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; INTESTINE CELL; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TH1 CELL;

EID: 0141494255     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(03)00076-8     Document Type: Article

References (34)

1. Butzler JP, Skirrow MB. Campylobacter enteritis. Clin Gastroenterol 1979;8:737-765.
2. Tauxe RV. Epidemiology of Campylobacter jejuni infections in the United States and other industrialized nations. In: Nachamkin I, Blaser MJ, Tompkins LS, editors. Campylobacter jejuni: current status and future trends. Washington, DC: American Society for Microbiology; 1992. p. 9-19.
3. Taylor DN. Campylobacter infections in developing countries. In: Nachamkin I, Blaser MJ, Tompkins LS, editors. Campylobacter jejuni: current status and future trends. Washington, DC: American Society for Microbiology; 1992. p. 20-30.
4. Bacon DJ, Alm RA, Burr DH, Hu L, Kopecko DJ, Ewing CP, Trust TJ, Guerry P. Involvement of a plasmid in virulence of Campylobacter jejuni 81-176. Infect Immun 2000;68: 4384-4390.
5. Pickett CL. Campylobacter toxins and their role in pathogenesis. In: Nachamkin I, Blaser MJ, editors. Campylobacter. Washington, DC: American Society for Microbiology; 2000. p. 179-190.
6. Wassenaar TM. Toxin production by Campylobacter. Clin Microbiol Rev 1997; 10:466-476.
7. Pickett CL, Pesci EC, Cottle DL, Russell G, Erdem AN, Zeytin H. Prevalence of cytolethal distending toxin production in Campylobacter jejuni and relatedness of Campylobacter spp. cdtB genes. Infect Immun 1996;64:2070-2078.
8. 2-phase cell cycle block. Infect Immun 1998;66: 1934-1940.
9. Black RE, Levine MM, Clements MI, Hughes TP, Blaser MJ. Experimental Campylobacter jejuni infections in humans. J Infect Dis 1988; 157:472-479.
10. Pancorbo PL, de Pablo MA, Ortega E, Puertollano MA, Gallego AM, Alvarez de Cienfuegos G. Potential intervention of Campylobacter jejuni in the modulation of murine immune response. Curr Microbiol 2001;43:209-214.
11. Abram M, Vukovic D, Wraber B, Doric M. Plasma cytokine response in mice with bacterial, infection. Mediators Inflamm 2000;5:229-234.
12. Bakhiet M, Diab A, Mustafa M, Zhu J, Lindqvist L, Link H. Potential role of autoantibodies in the regulation of cytokine responses in bacterial infections. Infect Immun 1997;65: 3300-3303.
13. Elkarim R, Mustafa M, Link H, Bakhiet M. Recovery from Guillain-Barrié syndrome is associated with increased levels of neutralizing autoantibodies to IFN-γ. Clin Immunol Immunopathol 1998;88:241-248.
14. Sander B, Andersson J, Andersson U. Assessment of cytokines by immunofluorescence and the paraformaldehyde-saponin procedure. Immunol Rev 1991; 119:65-93.
15. Lore K, Sonnerborg A, Spetz AL, Andersson U, Andersson J. Immunocytochemical detection of cytokines and chemokines in Langerhans cells and in vitro derived dendritic cells. J Immunol Methods 1998; 214:97-111.
16. Schulze-Koops H, Kalden JR. The balance of Th1/Th2 cytokines in rheumatoid arthritis. Best Pract Res Clin Rheumatol 2001;15:677-691.
17. Ishii H, Tanaka H, Katoh K, Nakamura H, Nagashima M, Yoshino S. Characterization of infiltrating T cells and Th1/Th2-type cytokines in the synovium of patients with osteoarthritis. Osteoarthritis Cartilage 2002;10:277-281.
18. Chikano S, Sawada K, Shimoyama T, Kashiwamura SI, Sugihara A, Sekikawa K, Terada N, Nakanishi K, Okamura H. IL-18 and IL-12 induce intestinal inflammation and fatty liver in mice in an IFN-gamma dependent manner. Gut 2001; 48:6-7.
19. Bao S, Beagley KW, France MP, Shen J, Husband AJ. Interferon-gamma plays a critical role in intestinal immunity against Salmonella typhimurium infection. Immunology 2000;99:464-472.
20. Raqib R, Gustafsson A, Andersson J, Bakhiet M. A systemic downregulation of gamma interferon production is associated with acute shigellosis. Infect Immun 1997;65: 5338-5341.
21. Raqib R, Ljungdahl A, Lindberg AA, Andersson U, Andersson J. Local entrapment of interferon gamma in the recovery from Shigella dysenteriae type 1 infection. Gut 1996;38: 328-336.
22. Carol L. Campylobacter toxins and their role in pathogenesis. In: Nachimakin I, Blaser MJ, editors. Campylobacter, 2nd ed. Washington DC, USA: American Society for Microbiology; 2000.
23. Denis M, Cambell D, Gregg EG. Interleukin-2 and granulocyte-macrophage colony-stimulating factor stimulate growth of a virulent strain of Escherichia call. Infect Immun 1991;59:1853-1856.
24. Porat R, Clark BD, Wolff SM, Dinarello CA. Enhancement of growth of virulent strains of Escherichia coil by interleukin-1. Science 1991;254:430-432.
25. Denis M. Interleukin-6 is used as a growth factor by virulent Mycobacterium avium: presence of specific receptors. Cell Immunol 1992;141:182-188.
26. Bakhiet M, Olsson T, Mhlanga J, Büscher P, Lycke N, Van der Meide P, Kristensson K. Human and rodent IFN-γ as a growth factor for Trypanosoma brucei brucei. Eur J Immunol 1996; 26:1359-1364.
27. Amiri P, Locksley RM, Parslow TG, Sadick M, Rector E, Ritter D, McKerrow JH. Tumor necrosis factor α restores granulomas and induces parasite egg-laying in schistosome-infected SCID mice. Nature 1992;356:604-607.
28. Lee JD, Rhoades K, Economou JS. Interleukin-4 inhibits the expression of tumour necrosis factors alpha and beta, interleukins-1 beta and-6 and interferon-gamma. Immunol Cell Biol 1995;73:57-61.
29. Paul WE. Interleukin 4/B cell stimulatory factor 1: one lymphokine, many functions. Faseb J 1987;1:456-461.
30. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989;170: 2081-2095.
31. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, Moore KW, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;146:3444-3451.
32. Schopf LR, Hoffmann KF, Cheever AW, Urban Jr. JF, Wynn TA. IL-10 is critical for host resistance and survival during gastrointestinal helminth infection. J Immunol 2002;168: 2383-2392.
33. Schmitz H, Fromm M, Bode H, Scholz P, Riecken EO, Schulzke JD. Tumor necrosis factor-alpha induces Cl- and K + secretion in human distal colon driven by prostaglandin E2. Am J Physiol 1996;271:669-674.
34. Mijatovic T, Kruys V, Caput D, Defrance P, Huez G. Interleukin-4 and -13 inhibit tumor necrosis factor-alpha mRNA translational activation in lipopolysaccharide-induced mouse macrophages. J Biol Chem 1997;272:14394-14398.